Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 2024Frontiers in ImmunologyOpen Access

Heterogeneity of macrophage activation syndrome and treatment progression

View Full Paper
Ask AI
Bookmark
Share

Authors

YDYuanji DongTWTing WangHWHuaxiang Wu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2024) studied this question.

synapsesocial.com/papers/68e6d58fb6db643587652bf0https://doi.org/10.3389/fimmu.2024.1389710
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis2022 · 63 citations
  2. 2Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation2023 · 15 citations
  3. 3Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome2023 · 330 citations
  4. 4Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice2020 · 21 citations